Baba Ramdev Patanjali Ayurved
-
{
- All
- News
- Videos
-
After Rooh Afza, Now Dabur: Fresh Court Setback For Ramdev's Patanjali
In a fresh setback to yoga guru Ramdev, the Delhi High Court on Thursday restrained his Patanjali Ayurved from running allegedly disparaging advertisements against Dabur Chyawanprash.
-
Court Rejects Patanjali Ayurved's Petition Against Rs 273.5 Crore GST Penalty
A division bench comprising Justices Shekhar B Saraf and Justice Vipin Chandra Dixit rejected Patanjali's argument that such penalties constitute criminal liability and can be imposed only after a criminal trial.
-
Baba Ramdev: The Yoga Guru And The Court Scrapes Behind His Business Empire
Meet Baba Ramdev - 'yoga guru', entrepreneur, and, over the past few years - a regular in courtrooms across India, courtesy patently misleading ads, unsubstantiated remarks about his Patanjali products' ability to 'cure' diseases such as COVID.
-
14 Patanjali Products That Had Their Licenses Suspended In Uttarakhand
The Uttarakhand government on Monday suspended the licenses of 14 products manufactured by Patanjali's Divya Pharmacy and Ayurved Ltd with immediate effect.
-
Patanjali Foods To Evaluate Proposal To Buy Group's Non-Food Business
Patanjali Foods Ltd, which is mainly into edible oils, on Friday said it will evaluate a proposal to acquire the non-food business of promoter group Patanjali Ayurved led by Baba Ramdev.
-
On Patanjali Misleading Ads Case, Supreme Court's Tough Questions For Centre
Hearing the Patanjali Ayurved misleading ads case, the Supreme Court has asked the government why it omitted Rule 170 from the Drugs and Magical Remedies Act, or DMR, which prohibits advertising of medicines as products with "magical" abilities.
-
Opinion | Patanjali Saga Is A Reminder That India Needs Better Ad Regulation
The need of the hour is a cohesive legal framework and an active awareness and self-regulation to guarantee quality communication between brands and the public.
-
"Please Spare Me," Begs Officer During Supreme Court Patanjali Ads Hearing
Patanjali Ads Case: A furious Supreme Court on Wednesday ripped into the Uttarakhand government's drug licencing authority, demanding to know why and how it failed to act against misleading ads floated by Baba Ramdev's Patanjali Ayurved.
-
Ramdev's Unconditional Apology To Supreme Court In Misleading Ads Case
After being pulled up by the Supreme Court, yoga guru Ramdev and his company Patanjali Ayurved's managing director Acharya Balkrishna have tendered an unconditional apology to the court.
-
"Absolute Defiance": Court Rebukes Patanjali, Centre In Misleading Ads Row
Patanjali Ayurved co-founder Baba Ramdev; the company's top executive, Acharya Balakrishna; and the centre were reprimanded by the Supreme Court Tuesday during a hearing on misleading advertisements.
-
"Be Ready For Action": Supreme Court To Ramdev In Misleading Ads Case
Yoga guru Ramdev appeared in person to face the Supreme Court today over Patanjali Ayurved's "misleading advertisements".
-
"Entire Country Is Being Taken For A Ride": Supreme Court On Patanjali
In a big setback for Patanjali Ayurved, co-owned by yoga guru Ramdev, the Supreme Court has issued a contempt notice to the company for issuing misleading advertisements. It has also pulled up the Centre for not taking action.
-
"Propaganda Against Patanjali, Will Reply In Court": Ramdev On Ad Row
Yoga teacher Ramdev has alleged a conspiratorial propaganda to tarnish the image of Patanjali Ayurved Lt, a day after the Supreme Court warned the company headed by Acharya Balkrishna against making "false" and "misleading" claims in ads.
-
Patanjali Clarifies On Coronil Certification, WHO Says "Not Reviewed"
Coronil, a medicine that claims to boost immunity against COVID-19, developed by yoga guru Ramdev-promoted Patanjali Ayurved has run into a controversy over claims of certification.
-
Never Said Patanjali Medicine Can Cure COVID-19: CEO Acharya Balkrishna
Yoga teacher Ramdev's Patanjali Ayurved never claimed it can cure COVID-19 with its medicines, Coronil and Swasari, the firm's Chief Executive Officer Acharya Balkrishna said on Tuesday, adding it just shared the favourable outcome of clinical trials on patients.
-
After Rooh Afza, Now Dabur: Fresh Court Setback For Ramdev's Patanjali
In a fresh setback to yoga guru Ramdev, the Delhi High Court on Thursday restrained his Patanjali Ayurved from running allegedly disparaging advertisements against Dabur Chyawanprash.
-
Court Rejects Patanjali Ayurved's Petition Against Rs 273.5 Crore GST Penalty
A division bench comprising Justices Shekhar B Saraf and Justice Vipin Chandra Dixit rejected Patanjali's argument that such penalties constitute criminal liability and can be imposed only after a criminal trial.
-
Baba Ramdev: The Yoga Guru And The Court Scrapes Behind His Business Empire
Meet Baba Ramdev - 'yoga guru', entrepreneur, and, over the past few years - a regular in courtrooms across India, courtesy patently misleading ads, unsubstantiated remarks about his Patanjali products' ability to 'cure' diseases such as COVID.
-
14 Patanjali Products That Had Their Licenses Suspended In Uttarakhand
The Uttarakhand government on Monday suspended the licenses of 14 products manufactured by Patanjali's Divya Pharmacy and Ayurved Ltd with immediate effect.
-
Patanjali Foods To Evaluate Proposal To Buy Group's Non-Food Business
Patanjali Foods Ltd, which is mainly into edible oils, on Friday said it will evaluate a proposal to acquire the non-food business of promoter group Patanjali Ayurved led by Baba Ramdev.
-
On Patanjali Misleading Ads Case, Supreme Court's Tough Questions For Centre
Hearing the Patanjali Ayurved misleading ads case, the Supreme Court has asked the government why it omitted Rule 170 from the Drugs and Magical Remedies Act, or DMR, which prohibits advertising of medicines as products with "magical" abilities.
-
Opinion | Patanjali Saga Is A Reminder That India Needs Better Ad Regulation
The need of the hour is a cohesive legal framework and an active awareness and self-regulation to guarantee quality communication between brands and the public.
-
"Please Spare Me," Begs Officer During Supreme Court Patanjali Ads Hearing
Patanjali Ads Case: A furious Supreme Court on Wednesday ripped into the Uttarakhand government's drug licencing authority, demanding to know why and how it failed to act against misleading ads floated by Baba Ramdev's Patanjali Ayurved.
-
Ramdev's Unconditional Apology To Supreme Court In Misleading Ads Case
After being pulled up by the Supreme Court, yoga guru Ramdev and his company Patanjali Ayurved's managing director Acharya Balkrishna have tendered an unconditional apology to the court.
-
"Absolute Defiance": Court Rebukes Patanjali, Centre In Misleading Ads Row
Patanjali Ayurved co-founder Baba Ramdev; the company's top executive, Acharya Balakrishna; and the centre were reprimanded by the Supreme Court Tuesday during a hearing on misleading advertisements.
-
"Be Ready For Action": Supreme Court To Ramdev In Misleading Ads Case
Yoga guru Ramdev appeared in person to face the Supreme Court today over Patanjali Ayurved's "misleading advertisements".
-
"Entire Country Is Being Taken For A Ride": Supreme Court On Patanjali
In a big setback for Patanjali Ayurved, co-owned by yoga guru Ramdev, the Supreme Court has issued a contempt notice to the company for issuing misleading advertisements. It has also pulled up the Centre for not taking action.
-
"Propaganda Against Patanjali, Will Reply In Court": Ramdev On Ad Row
Yoga teacher Ramdev has alleged a conspiratorial propaganda to tarnish the image of Patanjali Ayurved Lt, a day after the Supreme Court warned the company headed by Acharya Balkrishna against making "false" and "misleading" claims in ads.
-
Patanjali Clarifies On Coronil Certification, WHO Says "Not Reviewed"
Coronil, a medicine that claims to boost immunity against COVID-19, developed by yoga guru Ramdev-promoted Patanjali Ayurved has run into a controversy over claims of certification.
-
Never Said Patanjali Medicine Can Cure COVID-19: CEO Acharya Balkrishna
Yoga teacher Ramdev's Patanjali Ayurved never claimed it can cure COVID-19 with its medicines, Coronil and Swasari, the firm's Chief Executive Officer Acharya Balkrishna said on Tuesday, adding it just shared the favourable outcome of clinical trials on patients.
